| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
15,877 |
14,955 |
$960K |
| 80053 |
Comprehensive metabolic panel |
57,059 |
52,909 |
$406K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
10,682 |
10,386 |
$389K |
| 84443 |
Thyroid stimulating hormone (TSH) |
37,921 |
36,602 |
$385K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
10,559 |
10,274 |
$385K |
| 0240U |
|
3,038 |
2,962 |
$346K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,982 |
1,956 |
$230K |
| 80061 |
Lipid panel |
24,881 |
24,058 |
$220K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
10,914 |
10,431 |
$213K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,079 |
4,990 |
$208K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
27,820 |
27,012 |
$206K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
55,364 |
49,821 |
$179K |
| 80081 |
|
2,129 |
2,051 |
$168K |
| 86003 |
|
1,170 |
859 |
$133K |
| 82728 |
|
8,530 |
8,249 |
$110K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14,766 |
13,998 |
$109K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,280 |
3,212 |
$106K |
| 87660 |
|
5,290 |
5,103 |
$104K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,973 |
6,834 |
$95K |
| 84439 |
|
12,185 |
11,747 |
$93K |
| 88142 |
|
5,555 |
5,474 |
$92K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,366 |
4,302 |
$90K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
10,433 |
10,115 |
$90K |
| 85027 |
|
11,190 |
10,734 |
$70K |
| 87081 |
|
9,850 |
9,492 |
$66K |
| 86803 |
|
5,439 |
5,323 |
$61K |
| 87077 |
|
8,071 |
7,357 |
$58K |
| 87480 |
|
5,284 |
5,100 |
$57K |
| 83655 |
|
5,166 |
4,921 |
$56K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,826 |
1,711 |
$56K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,119 |
10,014 |
$54K |
| 87510 |
|
5,288 |
5,101 |
$53K |
| 82607 |
|
4,959 |
4,783 |
$51K |
| 87186 |
|
6,341 |
6,025 |
$49K |
| 83550 |
|
4,955 |
4,815 |
$41K |
| 84702 |
|
4,567 |
3,516 |
$41K |
| 81001 |
|
15,070 |
14,200 |
$38K |
| 84403 |
|
1,466 |
1,389 |
$32K |
| 87653 |
|
874 |
867 |
$29K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
77 |
77 |
$27K |
| 83540 |
|
6,959 |
6,727 |
$26K |
| 84153 |
|
2,041 |
1,965 |
$25K |
| 83970 |
|
1,881 |
1,820 |
$25K |
| 82784 |
|
1,924 |
1,780 |
$24K |
| 82570 |
|
5,908 |
5,479 |
$21K |
| 82950 |
|
3,416 |
3,365 |
$20K |
| 86140 |
|
4,716 |
4,513 |
$19K |
| 86038 |
|
1,578 |
1,527 |
$18K |
| 83001 |
|
865 |
835 |
$17K |
| 84480 |
|
1,312 |
1,273 |
$17K |
| 82746 |
|
1,601 |
1,548 |
$17K |
| 84703 |
|
2,006 |
1,883 |
$16K |
| 87340 |
|
1,719 |
1,692 |
$16K |
| 83516 |
|
1,610 |
1,514 |
$15K |
| 83525 |
|
1,400 |
1,332 |
$14K |
| 84146 |
|
726 |
707 |
$14K |
| 87070 |
|
2,955 |
2,793 |
$14K |
| 80076 |
|
1,868 |
1,788 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
501 |
487 |
$13K |
| 83735 |
|
3,043 |
2,518 |
$13K |
| 85651 |
|
3,947 |
3,783 |
$12K |
| 83002 |
|
571 |
543 |
$12K |
| 83880 |
|
1,013 |
952 |
$12K |
| 82670 |
|
336 |
326 |
$11K |
| 86592 |
|
2,685 |
2,643 |
$11K |
| 80164 |
|
1,436 |
1,370 |
$10K |
| 84305 |
|
583 |
568 |
$10K |
| 82947 |
|
2,431 |
2,323 |
$10K |
| 87205 |
|
2,972 |
2,804 |
$10K |
| 82105 |
|
888 |
860 |
$10K |
| 86376 |
|
585 |
576 |
$9K |
| 86762 |
|
1,263 |
1,247 |
$9K |
| 82043 |
|
3,861 |
3,690 |
$9K |
| 87536 |
|
147 |
145 |
$9K |
| 86850 |
|
1,281 |
1,252 |
$8K |
| 80074 |
|
296 |
286 |
$8K |
| 84156 |
|
2,544 |
2,256 |
$8K |
| 82565 |
|
1,965 |
1,835 |
$7K |
| 84450 |
|
1,735 |
1,626 |
$6K |
| 84550 |
|
1,891 |
1,691 |
$6K |
| 84460 |
|
1,474 |
1,383 |
$6K |
| 83615 |
|
1,316 |
1,172 |
$6K |
| 82550 |
|
1,276 |
1,203 |
$6K |
| 86800 |
|
300 |
291 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
132 |
127 |
$5K |
| 82533 |
|
333 |
247 |
$5K |
| 85610 |
|
2,063 |
1,576 |
$4K |
| 86765 |
|
921 |
884 |
$4K |
| 84402 |
|
184 |
177 |
$4K |
| 81003 |
|
5,251 |
4,814 |
$4K |
| 85045 |
|
1,003 |
982 |
$4K |
| 83690 |
|
795 |
769 |
$4K |
| 82951 |
|
255 |
248 |
$4K |
| 84100 |
|
1,113 |
982 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
526 |
508 |
$4K |
| 86780 |
|
297 |
295 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
452 |
436 |
$3K |
| 86430 |
|
603 |
587 |
$3K |
| 87807 |
|
207 |
204 |
$3K |
| 80069 |
|
603 |
553 |
$3K |
| 84144 |
|
128 |
106 |
$3K |
| 86235 |
|
63 |
54 |
$3K |
| 85044 |
|
519 |
504 |
$2K |
| 86481 |
|
55 |
53 |
$2K |
| 86160 |
|
146 |
111 |
$2K |
| 86901 |
|
621 |
614 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36 |
36 |
$2K |
| 82977 |
|
389 |
365 |
$2K |
| 85046 |
|
367 |
362 |
$2K |
| 86900 |
|
581 |
573 |
$2K |
| 84425 |
|
105 |
104 |
$2K |
| 86706 |
|
163 |
161 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
12 |
12 |
$1K |
| 87210 |
|
322 |
315 |
$1K |
| 86735 |
|
267 |
260 |
$1K |
| 86364 |
|
256 |
254 |
$1K |
| 87147 |
|
215 |
202 |
$1K |
| 87220 |
|
377 |
360 |
$1K |
| 86225 |
|
108 |
102 |
$1K |
| 85652 |
|
606 |
595 |
$1K |
| 86200 |
|
89 |
88 |
$1K |
| 82627 |
|
42 |
42 |
$947.92 |
| 80359 |
|
82 |
73 |
$877.73 |
| 80346 |
|
81 |
72 |
$870.00 |
| 80358 |
|
81 |
72 |
$859.54 |
| 80348 |
|
81 |
72 |
$857.95 |
| 84155 |
|
482 |
460 |
$857.80 |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
30 |
30 |
$845.35 |
| 80372 |
|
81 |
72 |
$771.00 |
| 80373 |
|
81 |
72 |
$771.00 |
| 86308 |
|
110 |
107 |
$698.85 |
| 80055 |
|
15 |
15 |
$647.96 |
| 82248 |
|
310 |
299 |
$614.71 |
| 83721 |
|
142 |
139 |
$609.41 |
| 83921 |
|
52 |
51 |
$609.12 |
| 81025 |
|
89 |
85 |
$600.33 |
| 80177 |
|
68 |
66 |
$532.75 |
| 86696 |
|
29 |
26 |
$525.28 |
| 83498 |
|
17 |
17 |
$484.82 |
| 80324 |
|
80 |
71 |
$446.32 |
| 80365 |
|
81 |
72 |
$444.80 |
| 80354 |
|
81 |
72 |
$444.80 |
| 80361 |
|
81 |
72 |
$442.80 |
| 80353 |
|
81 |
72 |
$424.98 |
| 84238 |
|
16 |
15 |
$302.85 |
| 86704 |
|
20 |
20 |
$267.51 |
| 85730 |
|
58 |
55 |
$231.85 |
| 80197 |
|
43 |
38 |
$222.72 |
| 84165 |
|
50 |
44 |
$220.23 |
| 87808 |
|
14 |
14 |
$189.86 |
| 86695 |
|
29 |
26 |
$180.29 |
| 85018 |
|
172 |
163 |
$150.49 |
| 83519 |
|
13 |
12 |
$148.68 |
| 84478 |
|
16 |
16 |
$98.79 |
| 86787 |
|
12 |
12 |
$92.41 |
| 80185 |
|
27 |
25 |
$79.40 |
| 85014 |
|
86 |
82 |
$77.28 |
| 80156 |
|
14 |
14 |
$76.66 |
| 82247 |
|
14 |
12 |
$72.54 |
| 36415 |
Collection of venous blood by venipuncture |
6,116 |
5,315 |
$38.04 |
| 82040 |
|
16 |
14 |
$21.59 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
567 |
542 |
$13.21 |
| 83521 |
|
13 |
13 |
$8.81 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
86 |
70 |
$8.56 |
| 0100U |
|
27 |
26 |
$0.00 |
| 80050 |
General health panel |
98 |
95 |
$0.00 |